Stavanger University Hospital, Department of Ophthalmology
Stavanger, 4016, Norway
Location status: Recruiting
NCT Number: NCT05589974
Patients with central serous chorioretinopathy (CSC) will be monitored with laser speckle flow graphy (LSFG), swept source optical coherence tomography (SS-OCT) and SS-OCT angiography (SS-OCTA). The aim is to unveil the flow and pulse wave characteristics of the choroidal circulation in acute CSC and chronic CSC.
Interested in participating?
Request Info18 year–70 year
All sexes
Observational
Stavanger, 4016, Norway
Location status: Recruiting
Acute CSC - The proposed study tests the hypothesis that choroidal blood flow characteristics are related to the eventual resolution of subretinal fluid. Such relation can shed light on pathophysiological disease mechanisms and constitute a biomarker for disease activity.
Chronic CSC - The proposed study tests the hypothesis that choroidal blood flow characteristics will change in response to standard treatment with PDT. The research of such changes will increase the understanding of the treatment response. This knowledge will help in the effort to understand the why some patients are non-responsive to the treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
-
b) Patient history and examination consistent with acute CSC c) Characteristic appearance of acute CSC on fundus autofluorescence (FAF) and OCT
Exclusion criteria
Chronic CSC are receiving one treatment before the observation period.
Time frame: 6 months
Relative changes in choroidal blood flow
Time frame: 6 months
Changes in the shapes of pulse curves
Time frame: 6 months
Changes in the tissue density
Time frame: 6 months
Changes in the morphology of the choroid
Contact information is provided by the study sponsor or research team.
Helse Stavanger HF
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06527326
Central Serous Chorioretinopathy, Eye Diseases
Hanzhou, Zhejiang, China
View Trial DetailsNCT06346405
Central Serous Chorioretinopathy, Eye Diseases
Roma, R, Italy
View Trial DetailsNCT02141308
Aneurysm, Arterial Occlusive Diseases
Portland, Oregon, United States
View Trial DetailsNCT06809751
Central Serous Chorioretinopathy, Eye Diseases
View Trial Details